Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants.
There is a need for new vaccines for tuberculosis (TB) that protect against adult pulmonary disease in regions where BCG is not effective. However, BCG could remain integral to TB control programmes because neonatal BCG protects against disseminated forms of childhood TB and many new vaccines rely o...
Main Authors: | Chris Finan, Martin O C Ota, Arnaud Marchant, Melanie J Newport |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2567029?pdf=render |
Similar Items
-
A case of Mycobacterium bovis Bacillus Calmette-Guérin (BCG) strain meningitis and ventriculitis following BCG vaccination
by: Mihoko Furuichi, et al.
Published: (2020-11-01) -
Growth inhibition of HeLa cell by internalization of <it>Mycobacterium bovis </it>Bacillus Calmette-Guérin (BCG) Tokyo
by: Asahina Izumi, et al.
Published: (2009-12-01) -
Mycobacterium bovis infection of a femorofemoral bypass graft following intravesical Bacillus Calmette–Guérin (BCG) immunotherapy
by: Ryan K. Meyer, M.D., et al.
Published: (2020-05-01) -
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
by: Suleiman Al-Hammadi, et al.
Published: (2017-05-01) -
The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
by: Junli Li, et al.
Published: (2021-01-01)